Sulbutiamine vs Semax
Side-by-side comparison of Sulbutiamine and Semax: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Sulbutiamine
Semax
Sulbutiamine
Sulbutiamine (chemical name: isobutyryl thiamine disulfide; trade names include Arcalion, Enerion, Bisibutiamine) is a lipophilic synthetic derivative of vitamin B1 (thiamine), developed in Japan in the 1960s by Sankyo…
No vendor price on file.
Full Sulbutiamine profileSemax
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP, 813 Da molecular weight) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. The compound is derived…
Lowest listed price: $32.90 across 5 listings
Full Semax profileSide-by-side comparison
| Attribute | Sulbutiamine | Semax |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Preclinical | Approved (Russia, since mid-1990s for stroke and cognitive disorders) |
| Mechanism of Action | Sulbutiamine's mechanism of action is thought to combine enhanced thiamine delivery to the central nervous system with additional neurotransmitter-level effects that the water-soluble parent vitamin does not readily produce. The mechanism has been… | Primary Mechanism: Multi-Pathway Neurotrophic Activation Semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective pathways. Unlike conventional nootropics that target a single system (modafinil… |
| Half-Life | — | ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes) |
| Typical Dose Range | — | 100-900 mcg intranasal daily (0.1% solution: 2-3 drops per nostril 2-3x daily); 1% solution used for acute stroke in Russian clinical protocols |
| Dosing Frequency | — | Intranasal 1–3 times daily |
| Administration | — | Intranasal |
| Side Effects | Sulbutiamine has a generally favourable safety profile in French clinical practice and in PubMed-indexed studies, but — as with any compound used off-label or outside rigorous regulatory oversight — users should understand both the common tolerability profile… | Overall Safety Profile Semax has an excellent safety profile across 20+ years of Russian clinical use. In acute stroke trials, cognitive studies, and pediatric applications, Semax has demonstrated consistent tolerability with minimal adverse event burden. This… |
| Molecular Weight | 702.89 g/mol | 813.9 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price History
5 data points- OF
- Half Nattys
- Ion Peptide
- BHG Labs
Sulbutiamine: potential benefits
- Motivation enhancement
- Memory improvement
- Fatigue reduction
- Mood elevation
- Dopamine D1 upregulation
- Erectile function
Semax: potential benefits
- Rapid BDNF/TrkB upregulation in the hippocampus, supporting synaptic plasticity and learning (PMID: 16996037)
- Neuroprotective, immunomodulatory gene-expression changes in focal cerebral ischemia (middle cerebral artery occlusion) models (PMID: 28255762)
- Cognitive enhancement including improved attention, working memory, and processing speed
- Dopaminergic modulation that may support motivation and executive function (preclinical data)
- Stroke recovery facilitation - accelerated functional recovery and improved Barthel Index in ischemic stroke patients; approved in Russia for ischemic stroke (PMID: 29798983)
- Anxiolytic and anti-asthenic effects reported in Russian clinical use, attributed to neurotrophic and monoaminergic modulation
- Non-addictive cognitive support without tolerance development or withdrawal at standard doses
Frequently asked
What's the difference between Sulbutiamine and Semax?
Sulbutiamine is a nootropics that sulbutiamine's mechanism of action is thought to combine enhanced thiamine delivery to the central nervous system with additional neurotransmitter-level effects that the…. Semax is a nootropics that primary mechanism: multi-pathway neurotrophic activation semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective…. The two differ in mechanism, half-life (not reported vs ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes)), and typical dose range.
Which has the longer half-life, Sulbutiamine or Semax?
Sulbutiamine has a half-life of not reported. Semax has a half-life of ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Sulbutiamine and Semax?
Stacking depends on mechanism overlap, safety profile, and goals. Sulbutiamine and Semax should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Sulbutiamine or Semax
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.